Keyphrases
Embolic Stroke
96%
Stroke Model
62%
Cerebral Ischemia
40%
Experimental Stroke
40%
Drug-induced Hypothermia
36%
Amphetamine
36%
Embolization
32%
Hypothermia
30%
Infarct Size
28%
Transient Middle Cerebral Artery Occlusion (tMCAO)
27%
Anticoagulation Treatment
27%
T Cells
24%
Rat Stroke Model
22%
Thrombolytic Therapy
21%
Recombinant Tissue Plasminogen Activator (rt-PA)
21%
Clinical Outcomes
21%
Thrombolysis
21%
Rat Hippocampus
20%
Global Cerebral Ischemia
20%
Infarct Volume
19%
Cognitive Deficits
18%
Dysphagia Screening
18%
Computer-assisted
18%
Inflammatory Cytokines
18%
Fine Motor
18%
Cryptogenic Stroke
18%
Oral Anticoagulant Therapy
18%
Modafinil
18%
Statin Therapy
18%
Necrosis-like
18%
Randomized Placebo-controlled Trial
18%
Behavioral Outcomes
18%
Staphylococcus Aureus
18%
CXCL2
18%
Temporal Features
18%
Caspase-3
18%
Therapeutic Target
18%
Chemokine Production
18%
Damage Production
18%
Physical Therapy
18%
Buprenorphine
18%
Macrophages
18%
Neuronal Death
18%
Spatial Characteristics
18%
Acutely Ill Patients
18%
Translational Stroke Research
18%
Cytokine Levels
18%
Occlusion
18%
Post-stroke Fatigue
18%
Transesophageal Echocardiography
18%
Neuroscience
Cerebrovascular Accident
100%
Embolic Stroke
96%
Brain Ischemia
64%
Hypothermia
49%
Amphetamine
36%
Alteplase
36%
Middle Cerebral Artery
35%
Ischemia
24%
Programmed Cell Death
22%
T Cell
21%
Hippocampus
20%
Antithrombotic
18%
Cognitive Disorder
18%
Experimental Autoimmune Encephalomyelitis
18%
Necrosis
18%
Agonist
18%
Modafinil
18%
Proinflammatory Cytokine
18%
Ipsapirone
18%
Calpain
18%
Cell Infiltration
18%
Statin
18%
5-HT1A Receptor
18%
Dexamethasone
18%
Neuronal Cell Death
18%
Thrombolytic Drug
18%
Group Therapy
18%
Chemokine
18%
Endoplasmic Reticulum Stress
18%
CHOP
18%
Neuroprotection
18%
Macrophage
18%
Pentasaccharide
15%
Cell Death
15%
